Analysis of current epilepsy treatment guidelines

Introduction: In 2017, the International League Against Epilepsy (ILAE) published a new classification of seizures. The purpose of this publication is to analyze the use of antiepileptic drugs in epilepsy therapy depending on the types of seizures classified according to ILAE 2017. State of the art...

Full description

Bibliographic Details
Main Authors: Marcin Kulczyński, Michał Marciniec, Klaudia Sapko, Remigiusz Ficek
Format: Article
Language:English
Published: Kazimierz Wielki University 2019-08-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/25674
_version_ 1818478659510468608
author Marcin Kulczyński
Michał Marciniec
Klaudia Sapko
Remigiusz Ficek
author_facet Marcin Kulczyński
Michał Marciniec
Klaudia Sapko
Remigiusz Ficek
author_sort Marcin Kulczyński
collection DOAJ
description Introduction: In 2017, the International League Against Epilepsy (ILAE) published a new classification of seizures. The purpose of this publication is to analyze the use of antiepileptic drugs in epilepsy therapy depending on the types of seizures classified according to ILAE 2017. State of the art: The new basic classification emphasizes mainly the location, where seizures begin in the brain, as the most important criterion to classify epileptic seizures. In focal onset seizures, 1st line of treatment in children is oxcarbazepine, while carbamazepine, levetiracetam, phenytoin and zonisamide is 1st choice in younger adults and gabapentin and lamotrigine in elderly patients. In younger adults valproic acid can be considered as second line treatment. In generalized tonic and atonic seizures carbamazepine, phenobarbital, phenytoin, topiramate, oxcarbazepine and valproic acid can be used both in children and adults. Safe and effective drugs in myoclonic and myoclonic-atonic seizures in all age groups are topiramate and valproic acid. In absence seizures, 1st line treatment in children is ethosuximide (used exclusively in this seizures type) and valproic acid, while carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin, topiramate, valproic acid, gabapentin, levetiracetam and vigabatrin are commonly used in adult patients. Non-pharmacological approaches, used in refractory epilepsy, include: surgical resection of the seizure focus, the ketogenic diet, vagus nerve stimulation and responsive neurostimulation. Summary: The new ILAE classification corresponds well with the old guidelines well, which leads to simplifying and spreading the knowledge about epileptic seizures treatment.
first_indexed 2024-12-10T09:50:29Z
format Article
id doaj.art-7fe252455bfa481bbaa1c093261c814e
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-12-10T09:50:29Z
publishDate 2019-08-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-7fe252455bfa481bbaa1c093261c814e2022-12-22T01:53:40ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062019-08-0198Analysis of current epilepsy treatment guidelinesMarcin Kulczyński0Michał Marciniec1Klaudia Sapko2Remigiusz Ficek3Chair and Department of Neurology, Medical University of LublinChair and Department of Neurology, Medical University of LublinChair and Department of Neurology, Medical University of LublinChair and Department of Neurology, Medical University of LublinIntroduction: In 2017, the International League Against Epilepsy (ILAE) published a new classification of seizures. The purpose of this publication is to analyze the use of antiepileptic drugs in epilepsy therapy depending on the types of seizures classified according to ILAE 2017. State of the art: The new basic classification emphasizes mainly the location, where seizures begin in the brain, as the most important criterion to classify epileptic seizures. In focal onset seizures, 1st line of treatment in children is oxcarbazepine, while carbamazepine, levetiracetam, phenytoin and zonisamide is 1st choice in younger adults and gabapentin and lamotrigine in elderly patients. In younger adults valproic acid can be considered as second line treatment. In generalized tonic and atonic seizures carbamazepine, phenobarbital, phenytoin, topiramate, oxcarbazepine and valproic acid can be used both in children and adults. Safe and effective drugs in myoclonic and myoclonic-atonic seizures in all age groups are topiramate and valproic acid. In absence seizures, 1st line treatment in children is ethosuximide (used exclusively in this seizures type) and valproic acid, while carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin, topiramate, valproic acid, gabapentin, levetiracetam and vigabatrin are commonly used in adult patients. Non-pharmacological approaches, used in refractory epilepsy, include: surgical resection of the seizure focus, the ketogenic diet, vagus nerve stimulation and responsive neurostimulation. Summary: The new ILAE classification corresponds well with the old guidelines well, which leads to simplifying and spreading the knowledge about epileptic seizures treatment.https://apcz.umk.pl/JEHS/article/view/25674epilepsyantiepileptic drugsepileptic seizures
spellingShingle Marcin Kulczyński
Michał Marciniec
Klaudia Sapko
Remigiusz Ficek
Analysis of current epilepsy treatment guidelines
Journal of Education, Health and Sport
epilepsy
antiepileptic drugs
epileptic seizures
title Analysis of current epilepsy treatment guidelines
title_full Analysis of current epilepsy treatment guidelines
title_fullStr Analysis of current epilepsy treatment guidelines
title_full_unstemmed Analysis of current epilepsy treatment guidelines
title_short Analysis of current epilepsy treatment guidelines
title_sort analysis of current epilepsy treatment guidelines
topic epilepsy
antiepileptic drugs
epileptic seizures
url https://apcz.umk.pl/JEHS/article/view/25674
work_keys_str_mv AT marcinkulczynski analysisofcurrentepilepsytreatmentguidelines
AT michałmarciniec analysisofcurrentepilepsytreatmentguidelines
AT klaudiasapko analysisofcurrentepilepsytreatmentguidelines
AT remigiuszficek analysisofcurrentepilepsytreatmentguidelines